Dillione Janet 4
4 · CorMedix Inc. · Filed Dec 4, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Dillione Janet
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-02$4.03/sh+12,210$49,206→ 60,683 total - Exercise/Conversion
Common Stock
2025-12-02$4.43/sh+15,124$66,999→ 75,807 total - Exercise/Conversion
Common Stock
2025-12-02$3.55/sh+19,323$68,597→ 95,130 total - Sale
Common Stock
2025-12-02$10.00/sh−46,657$466,570→ 48,473 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-02−12,210→ 0 totalExercise: $4.03Exp: 2032-02-22→ Common Stock (12,210 underlying) - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-02−15,124→ 0 totalExercise: $4.43Exp: 2033-01-14→ Common Stock (15,124 underlying) - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-02−19,323→ 5,000 totalExercise: $3.55Exp: 2034-03-05→ Common Stock (19,323 underlying)
Footnotes (3)
- [F1]These options were granted on 02/22/2022. These options are fully vested.
- [F2]These options were granted on 01/14/2023. These options are fully vested.
- [F3]These options were granted on 03/05/2024. These options are fully vested.